All posts tagged
“This is the First Time CAR-T Has Ever Worked on Acute Myeloid Leukemia“
French CAR-T Developer Raises $164M Despite a Challenging Road
Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?
Cancer Trial Halted in the UK After Overdosing First Patient
The Most Important Battle in Gene Editing: CRISPR versus TALEN
Could This Parisian Biotech Startup’s Cancer Treatment Compete With Merck and Novartis?
Yet Another Checkpoint Inhibitor Goes to Trial with Bavarian Nordic’s Cancer Vaccine
FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s
French Biotech Gets a CRISPR Patent for CAR-T Research
Bicycle’s First Peptide-Toxin Conjugate Enters the Clinic for Solid Tumors
British Cancer Vaccine Boosts 5-Year Survival in Late Stage Melanoma
Scottish CAR-T Biotech Adds Another Stellar Partner to Its Roster
Labiotech UG, All Rights Reserved -